(CIA) Citizens - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1747401008
CIA: Life, Insurance, Property, Accident, Health
Citizens, Inc. (NYSE:CIA) operates as a life insurance provider with a dual-segment business model: Life Insurance and Home Service Insurance. The Life Insurance segment targets non-U.S. residents, offering whole life and endowment policies through independent agencies and consultants. This segments product distribution is tailored to international markets, leveraging a network of intermediaries to reach a diverse clientele. The Home Service Insurance segment focuses on middle- and lower-income households in Louisiana, Mississippi, and Arkansas, providing final expense life insurance and property insurance. This segment utilizes funeral homes and independent agents for distribution, aligning with the financial needs of its target demographic. Additionally, the company offers accident and health insurance policies, complementing its life insurance offerings. Established in 1969, Citizens, Inc. is headquartered in Austin, Texas, and has built a presence in both domestic and international markets through its specialized insurance products.
Over the next three months, Citizens, Inc.s stock price is expected to face headwinds due to the decline below the 20-day SMA of 5.19, signaling potential bearish momentum. The ATR of 0.30 indicates moderate price fluctuations, with resistance likely at the SMA 50 level of 4.66. Fundamentally, with a P/E of 12.05 and a forward P/E of 13.68, the companys valuation reflects expectations of modest growth. The RoE of 10.61% suggests efficient operations, though rising interest rates may impact policy sales and profitability. Overall, the stock is projected to trade in a narrow range with downside risks tied to broader market conditions and interest rate sensitivity in the life insurance sector.
Additional Sources for CIA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CIA Stock Overview
Market Cap in USD | 256m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1988-12-05 |
CIA Stock Ratings
Growth 5y | -10.2% |
Fundamental | 47.5% |
Dividend | 0.0% |
Rel. Strength | 78.6 |
Analysts | - |
Fair Price Momentum | 4.50 USD |
Fair Price DCF | 16.01 USD |
CIA Dividends
No Dividends PaidCIA Growth Ratios
Growth Correlation 3m | 39% |
Growth Correlation 12m | 87.4% |
Growth Correlation 5y | -67.6% |
CAGR 5y | -3.47% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | 1.23 |
Alpha | 110.98 |
Beta | 0.106 |
Volatility | 67.29% |
Current Volume | 219.9k |
Average Volume 20d | 117.1k |
As of April 01, 2025, the stock is trading at USD 4.55 with a total of 219,898 shares traded.
Over the past week, the price has changed by -11.65%, over one month by -5.41%, over three months by +13.47% and over the past year by +115.64%.
Partly, yes. Based on ValueRay Fundamental Analyses, Citizens (NYSE:CIA) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.52 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CIA as of April 2025 is 4.50. This means that CIA is currently overvalued and has a potential downside of -1.1%.
Citizens has no consensus analysts rating.
According to ValueRays Forecast Model, CIA Citizens will be worth about 4.9 in April 2026. The stock is currently trading at 4.55. This means that the stock has a potential upside of +6.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5 | 9.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 4.9 | 6.8% |